Paper · 38201484
Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review.
Pantaleo A and 10 others. Cancers (Basel), 2023. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review. Papers, record 38201484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38201484
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| IG-23794 2020-2024 to Cristiano Simone | Italian Association for Cancer Research | PubMed | ||
| AIRC Felloship for Italy ID 26678-2021 to Martina Lepore Signorile | Italian Association for Cancer Research | PubMed | ||
| Ricerca Corrente 2021-2023 to Cristiano Simone | Italian Ministry of Health | PubMed | ||
| Ricerca Corrente 2022-2024 to Vittoria Disciglio | Italian Ministry of Health | PubMed | ||
| Ricerca Corrente 2022-2024 to Candida Fasano | Italian Ministry of Health | PubMed | ||
| Ricerca Corrente 2023-2025 to Valentina Grossi | Italian Ministry of Health | PubMed | ||
| Starting Grant SG-2019-12371540 to Paola Sanese | Italian Ministry of Health | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References233
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,059,070 | Pancreatic cancer: Advances and challenges. | Cell | 2023 | https://conductscience.org/library/papers/37059070 | PubMed |
| 2 | 14,735,200 | Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma. | Br J Cancer | 2004 | https://conductscience.org/library/papers/14735200 | PubMed |
| 3 | 35,805,029 | A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35805029 | PubMed |
| 4 | 37,313,463 | Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. | Front Oncol | 2023 | https://conductscience.org/library/papers/37313463 | PubMed |
| 5 | 25,356,972 | BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. | Genet Med | 2015 | https://conductscience.org/library/papers/25356972 | PubMed |
| 6 | 34,547,082 | Pancreatic Cancer: A Review. | JAMA | 2021 | https://conductscience.org/library/papers/34547082 | PubMed |
| 7 | 30,721,664 | Early Detection of Pancreatic Cancer: Opportunities and Challenges. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30721664 | PubMed |
| 8 | 35,625,944 | OncoPan®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625944 | PubMed |
| 9 | 28,979,722 | Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier. | World J Gastrointest Oncol | 2017 | https://conductscience.org/library/papers/28979722 | PubMed |
| 10 | 37,894,428 | Tumor Testing and Genetic Analysis to Identify Lynch Syndrome Patients in an Italian Colorectal Cancer Cohort. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894428 | PubMed |
1 to 10 of 233
See all 233 referencesCited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,877,528 | Strategy for early diagnosis of pancreatic cancer. | Front Gastroenterol (Lausanne) | 2026 | https://conductscience.org/library/papers/42877528 | PubMed |
| 42,177,254 | The interplay between tumor-intrinsic KRT6A and host-derived immune-nutritional status (PNI) defines prognosis in resectable PDAC. | Sci Rep | 2026 | https://conductscience.org/library/papers/42177254 | PubMed |
| 41,374,970 | KRAS-Wild Pancreatic Cancer-More Targets than Treatment Possibilities? | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41374970 | PubMed |
| 41,315,260 | Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. | Nat Commun | 2025 | https://conductscience.org/library/papers/41315260 | PubMed |
| 40,804,928 | Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40804928 | PubMed |
| 40,418,431 | Pancreatic adenocarcinoma in a patient with a germline RB1 pathogenic variant. | Fam Cancer | 2025 | https://conductscience.org/library/papers/40418431 | PubMed |
| 40,282,495 | Recent Advances and Challenges in the Treatment of Advanced Pancreatic Cancer: An Update on Completed and Ongoing Clinical Trials. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282495 | PubMed |
| 39,949,937 | TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcinoma. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/39949937 | PubMed |
| 39,860,372 | Hereditary Pancreatic Cancer: Advances in Genetic Testing, Early Detection Strategies, and Personalized Management. | J Clin Med | 2025 | https://conductscience.org/library/papers/39860372 | PubMed |
| 39,684,385 | Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684385 | PubMed |
1 to 10 of 12
See all 12 cited byGenes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| ATR | 545 | PubTator's text mining | https://conductscience.org/library/genes/545 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| EPCAM | 4,072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| MLH1 | 4,292 | PubTator's text mining | https://conductscience.org/library/genes/4292 | NCBI Gene |
| MSH2 | 4,436 | PubTator's text mining | https://conductscience.org/library/genes/4436 | NCBI Gene |
| MSH6 | 2,956 | PubTator's text mining | https://conductscience.org/library/genes/2956 | NCBI Gene |
| PALB2 | 79,728 | PubTator's text mining | https://conductscience.org/library/genes/79728 | NCBI Gene |
1 to 10 of 18
See all 18 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38201484
GET https://conductscience.org/api/papers/v1/38201484/references?page=2